期刊文献+

人破伤风免疫噬菌体单链抗体库的构建及体外亲和筛选 被引量:3

Construction of a human tetanus toxoid immune phage single-chain Fv antibody library and screening of scFv against tetanus toxin Hc fragment
原文传递
导出
摘要 目的构建人破伤风免疫噬菌体单链抗体库,筛选抗破伤风毒素重链C端(TeNT-Hc)的特异性单链抗体(scFv)。方法利用RT-PCR从5名破伤风抗体滴度较高的健康献浆员外周血淋巴细胞中获得全套人破伤风抗体VH和VL基因,经过重叠PCR将VH和VL基因连接获得scFv片段。将scFv片段克隆至pCANTAB5E载体,电转化大肠TG1感受态菌,获得抗体库。以TeNT-Hc为抗原对抗体库进行3轮筛选,获得特异性人源性抗TeNT-Hc单链抗体。scFv由pET32a(+)表达载体表达,产物包涵体采用HisTrap FF预装柱纯化并透析复性。采用非竞争酶免疫实验法测定scFv亲和常数(affinity constant,KD值)。检测scFv抑制TeNT-Hc与神经节苷脂GT1b结合的体外中和活性,计算抑制率。结果构建库容量为1×108的人破伤风免疫噬菌体单链抗体库,经过筛选获得3株特异性较好的人源性抗TeNT-Hc单链抗体。原核表达结果显示,3株scFv均以包涵体形式存在,表达量占菌体总蛋白的40%~45%。包涵体经洗涤、纯化和复性后,scFv均保持了与TeNT-Hc的特异结合活性,1 L培养物经纯化后可获得4~6 mg scFv蛋白。亲和力测定结果,27G、22D和S-4-7H-scFv的KD值分别为(1.25×10-7),(2.31×10-7)和(1.97×10-7)mol/L。3株抗体对TeNT-Hc与神经节苷脂GT1b结合的抑制率分别为64.5%,58.6%和51.5%。结论人破伤风免疫噬菌体单链抗体库的构建及具有体外中和活性的特异性抗TeNT-Hc单链抗体的获得,为人破伤风基因工程中和抗体的制备奠定了良好基础。 Objective To construct a human tetanus toxoid immune phage single-chaln Fv(scFv) antibody library and to screen scFv against tetanus toxin heavy chain C (Hc) fragment (TeNT-He). Methods The variable heavy ( VH ) and variable light (VL) genes were amplified from peripheral blood lymphocytes from five volunteers with high titer antibodies against tetanus toxoid. Gene encoding scFv fragments were constructed by SOE-PCR and then cloned into the phagemids vector pCANTABSE. The phagemids containing scFv gene were transformed into electrocompetent Escherichia coli TG1 cells to construct the antibody library. ScFv clones were screened by three rounds of panning with TeNT-Hc. ScFv protein was expressed by vector pET32a( + ) and purified by an affinity chromatography HisTrap FF. The inclusion of 3 scFvs'protein was via dialysis renaturation. Non-competitive enzyme immunoassay method was used to determine the affinity constant (KD) of 3 scFvs. The rate at which the scFv inhibits TeNT-Hc binding to ganglioside GT1 b showing neutralizing activity in vitro of scFv was calculated. Results A human tetanus toxoid immune phage single-chain Fv antibody library was construc- ted with a size of about 1 x 10s. Three scFvs were selected which bound specifically to TeNT-Hc named 27G ,22D and S-4- 7H-scFv. The expression of 3 scFvs in E. coil BL21 (DE3) as inclusion body accounted for about 40% to 45% of total bac- terial proteins. After the scFv inclusion bodies were washed, purified and renaturated, the seFv proteins maintained specif- ic binding activities to TeNT-Hc and the yield was 4 to 6 mg per litre. The KD of three scFvs was( 1.25× 10^-7 ), (2.31 ×10^-7 ) and ( 1.97×10^-7 ) mol/L while the inhibitory rate was 64.5%, 58.6% and 51.5%, respectively. Conclusion Successful construction of a human tentanus immune phage single-chain Fv antibody library and obtaining specific scFv against He which can inhibit the TeNT-He binding to ganglioside GTlbContribute much to the preparation of human engineering antibody against tetanus toxin.
出处 《军事医学》 CAS CSCD 北大核心 2013年第2期85-90,96,共7页 Military Medical Sciences
基金 国家杰出青年科学基金资助项目(81025018) 国家自然科学基金青年基金资助项目(81102360,81172980)
关键词 破伤风 破伤风毒素 单链抗体 逆转录聚合酶链反应 细菌噬菌体 tetanus tetanus toxin single-chain Fv antibody reverse transcriptase polymerase chain reaction bacteriophages
  • 相关文献

参考文献12

  • 1Lacy DB, Tepp W, Cohen AC, et al. Crystal structure of botulinum neurotoxin type A and implications for toxicity [ J ]. Nat Struct Biol, 1998,5 (10) : 898 - 902.
  • 2WHO. WHO position paper. Tetanus vaccine [J]. Wkly Epidemiol Rec ,2006,81 (20) :198 -208.
  • 3Alagappan K, Park R, Naderi S, et al. Evaluation for tetanus antibodies in Korean-Americans living in the New York area: a pilot study[J]. J Immigr Minor Health,2009,11(2) :105 '107.
  • 4焦玲.注射破伤风抗毒素致死1例[J].中国误诊学杂志,2008,8(14):3294-3294. 被引量:4
  • 5Sblattero D, Bradbury A. A definitive set of oligonueleotide primers for amplifying human V regions [ J ]. Immunotechnology, 1998, 3(4) : 271 -278.
  • 6Marks JD, Tristem M, Karpas A. Otigonucleotjde primers for polymerase chain reaction amplification of ,-anan immunoglobulin variable genes and design of family specific oligonucleotide probes [J]. Eur J Immunol, 1991,21(4) : 985 -991.
  • 7Winter G, Griffiths AD, Hawkins RE. Making antibodies by phage display technology [ J ]. An nu Rev Immunol, 1994, 12 (2) : 433 -455.
  • 8Qazi O, Sesardic D, Tierney R, et al. Reduction of the ganglioside binding activity of the tetanus toxin HC fragment destroys im- munogenicity: implications for development of novel tetanus vaccines[J]. Infect Immun,2006, 74(8) :4884 -4891.
  • 9Goonetilleke A, Harris JB. Clostridial neurotoxins[ J ]. J Neurol Neurosurg Psychiatry,2004,75 ( Suppl 3 ) : iii35 - iii39.
  • 10Rao KN, Kumaran D, Binz T, et al. Structural analysis of the catalytic domain of tetanus neurotoxin [ J ]. Toxicon, 2005, 45 (7) : 929 - 939.

共引文献3

同被引文献29

  • 1李华丽,何煜波.微生物毒素与食物安全[J].中国食物与营养,2004,10(10):12-15. 被引量:2
  • 2谢捷明,许建华,陈明晃,许盈,赵蓉,俞昌喜,吴国华.南瓜蛋白对B16细胞的诱导分化作用(简报)[J].福建医科大学学报,2004,38(4):394-394. 被引量:3
  • 3钱新宇,罗荣城,李黎波,廖旺军,罗宇玲.Photofrin-Herceptin偶联物对肿瘤细胞株的体外杀伤效应[J].第一军医大学学报,2005,25(8):975-978. 被引量:1
  • 4谢捷明,陈明晃,许盈,赵蓉,许建华,俞昌喜.八棱丝瓜蛋白-1对B16细胞的诱导分化作用[J].肿瘤防治杂志,2005,12(20):1521-1524. 被引量:6
  • 5谢捷明,陈明晃,许建华,等.南瓜蛋白在制药中的应用:中国专利,200510119741.2[P],2006-09-13.
  • 6Sliwkowski MX,Lofgren JA,Lewis GD,et al Noneclinical studies addressing the mechanism of action of Trastuzumab(Herceptin)[J].Semin Oncol,1999,26(4suppl 12):60-70.
  • 7Belselga J.Clinical trial of single-agent Trastuzumab(Herceptin)[J].Semin Oncol,2000,27(5 suppl 9):206.
  • 8Slamon DJ,Leyland-Jones,Shak S,et al.Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2[J].NEngl J Med,2001,344(11):783-92.
  • 9Bartsch R,De Vries C,Pluschnig U,et al.Predicting for activity of second-line trastuzumab-based therapy in HER2-positive advanced breast cancer[J].BMC Cancer,2009,9(1):367.
  • 10沈倍奋.免疫毒素抗人T琳巴细胞Mc A b和蓖席毒素结合物的制备及其细胞毒性质[J].中华微生物和免疫学杂志,1985,5(4):209-215.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部